Abstract
Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression.
Highlights
These concerns call into question the validity of the quantification data shown in Figs 4B, 5B, and 6C
The authors and PLOS ONE Editors retract this article in light of the concerns raised and the unavailability of underlying data to support the results reported in the article
Summary
These concerns call into question the validity of the quantification data shown in Figs 4B, 5B, and 6C. Retraction: Sinomenine Sensitizes MultidrugResistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
